Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feifei Teng

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 10, 2025
Convertible ROS Nanocatalyst/Eliminator for Enhancing Tumor Radio-Immunotherapy and Relieving Radiation EnteritisMengmeng Zhang, Xinyu Zhang, Chenyu Wang, et al.
Nature Communications|March 11, 2026
Identification of altered immune landscape at single-cell resolution in NSCLC brain metastasis and its association with poor immune checkpoint inhibitor responsesMenglin Bai, Tianwen Yin, Xiaohui Li, et al.
Genes & Diseases|February 6, 2025
Utilization of cuproptosis-related lncRNAs to predict the prognosis of pancreatic cancer patients and explore their roles in immune cell infiltration and prognosis evaluationKaili Liao, Jinting Cheng, Xiajing Yu, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II studyGuoxin Cai, Pingping Song, Zhendan Wang, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 10, 2025
Convertible ROS Nanocatalyst/Eliminator for Enhancing Tumor Radio-Immunotherapy and Relieving Radiation EnteritisMengmeng Zhang, Xinyu Zhang, Chenyu Wang, et al.
Nature Communications|March 11, 2026
Identification of altered immune landscape at single-cell resolution in NSCLC brain metastasis and its association with poor immune checkpoint inhibitor responsesMenglin Bai, Tianwen Yin, Xiaohui Li, et al.
Genes & Diseases|February 6, 2025
Utilization of cuproptosis-related lncRNAs to predict the prognosis of pancreatic cancer patients and explore their roles in immune cell infiltration and prognosis evaluationKaili Liao, Jinting Cheng, Xiajing Yu, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II studyGuoxin Cai, Pingping Song, Zhendan Wang, et al.
Pageof 6